title: Alopecia areata during treatment with adalimumab: therapy with an alternative TNF-alpha inhibitor is possible.
authors.forename: Carolin
authors.initials: C
authors.lastname: Zschoche
authors.forename: Mona
authors.initials: M
authors.lastname: Bidier
authors.forename: Eva
authors.initials: E
authors.lastname: Hadaschik
mesh_terms: D000068879:Adalimumab; D000506:Alopecia Areata / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab